Four Decades for Justice
Joyce Law is a senior attorney in Cravath’s Corporate Department, with concentration in the real estate practice area. Ms. Law’s experience includes real estate development, acquisitions and dispositions, as well as real estate financing, including fund credit facilities and municipal financings, real estate fund work, and leasing transactions.
Ms. Law also regularly assists on the real estate aspects of various corporate mergers and acquisitions.
Ms. Law’s clients have included Morgan Stanley, IBM, Kraft Foods Inc., Bristol‑Myers Squibb Company, Unilever, Jones Apparel Group, Inc., Westbrook Partners and The Dermot Company, Inc.
Ms. Law was born in Rapid City, South Dakota. She received a Bachelor of Commerce with distinction from the University of Alberta in 1994 and a J.D. from Boston University in 1997. Ms. Law joined Cravath in 2001 and was elected a senior attorney in 2015. Prior to joining Cravath, she was associated with a real estate developer in New York.
Ms. Law also regularly assists on the real estate aspects of various corporate mergers and acquisitions.
Ms. Law’s clients have included Morgan Stanley, IBM, Kraft Foods Inc., Bristol‑Myers Squibb Company, Unilever, Jones Apparel Group, Inc., Westbrook Partners and The Dermot Company, Inc.
Ms. Law was born in Rapid City, South Dakota. She received a Bachelor of Commerce with distinction from the University of Alberta in 1994 and a J.D. from Boston University in 1997. Ms. Law joined Cravath in 2001 and was elected a senior attorney in 2015. Prior to joining Cravath, she was associated with a real estate developer in New York.
Deals & Cases
February 12, 2024
On February 12, 2024, CymaBay Therapeutics (“CymaBay”) and Gilead Sciences, Inc. (“Gilead”) announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis, complements Gilead’s existing liver portfolio and aligns with its longstanding commitment to bringing transformational medicines to patients. Cravath is representing CymaBay in connection with the transaction.
Deals & Cases
February 12, 2024
On February 12, 2024, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that on February 11, 2024, it entered into a definitive agreement to acquire 20 active aggregates operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (“BWI Southeast”) for $2.05 billion in cash. Additionally, on February 9, 2024, Martin Marietta completed its previously announced divestiture of its South Texas cement and related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transactions.
Deals & Cases
January 31, 2024
On January 31, 2024, Health Care Service Corporation (“HCSC”), the country’s largest customer‑owned health insurer, announced that it has signed a definitive agreement with The Cigna Group (“Cigna”) to acquire its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies businesses for a purchase price of $3.3 billion. Cigna’s Medicare plans currently serve 3.6 million Medicare members. Cravath is representing HCSC in connection with the transaction.
Deals & Cases
January 25, 2024
On January 18, 2024, IBM announced it has signed a definitive agreement to acquire application modernization capabilities from Advanced, bringing a combination of talent, tools and knowledge to enhance IBM Consulting’s mainframe application and data modernization services. Cravath is representing IBM in connection with the transaction.
Deals & Cases
December 20, 2023
On December 20, 2023, Aon plc (“Aon”), a leading global professional services firm, announced the signing of a definitive agreement to acquire NFP, a leading middle‑market property and casualty broker, benefits consultant, wealth manager and retirement plan advisor, from funds affiliated with NFP’s main capital sponsor, Madison Dearborn Partners, and funds affiliated with HPS Investment Partners. Under the terms of the transaction, Aon will acquire NFP for a total consideration estimated to be $13.4 billion at the time of close, which will be funded by $7 billion of cash and $6.4 billion of Aon stock. Cravath is representing Aon in connection with the transaction.
Joyce Law is a senior attorney in Cravath’s Corporate Department, with concentration in the real estate practice area. Ms. Law’s experience includes real estate development, acquisitions and dispositions, as well as real estate financing, including fund credit facilities and municipal financings, real estate fund work, and leasing transactions.
Ms. Law also regularly assists on the real estate aspects of various corporate mergers and acquisitions.
Ms. Law’s clients have included Morgan Stanley, IBM, Kraft Foods Inc., Bristol‑Myers Squibb Company, Unilever, Jones Apparel Group, Inc., Westbrook Partners and The Dermot Company, Inc.
Ms. Law was born in Rapid City, South Dakota. She received a Bachelor of Commerce with distinction from the University of Alberta in 1994 and a J.D. from Boston University in 1997. Ms. Law joined Cravath in 2001 and was elected a senior attorney in 2015. Prior to joining Cravath, she was associated with a real estate developer in New York.
Ms. Law also regularly assists on the real estate aspects of various corporate mergers and acquisitions.
Ms. Law’s clients have included Morgan Stanley, IBM, Kraft Foods Inc., Bristol‑Myers Squibb Company, Unilever, Jones Apparel Group, Inc., Westbrook Partners and The Dermot Company, Inc.
Ms. Law was born in Rapid City, South Dakota. She received a Bachelor of Commerce with distinction from the University of Alberta in 1994 and a J.D. from Boston University in 1997. Ms. Law joined Cravath in 2001 and was elected a senior attorney in 2015. Prior to joining Cravath, she was associated with a real estate developer in New York.
Deals & Cases
February 12, 2024
On February 12, 2024, CymaBay Therapeutics (“CymaBay”) and Gilead Sciences, Inc. (“Gilead”) announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis, complements Gilead’s existing liver portfolio and aligns with its longstanding commitment to bringing transformational medicines to patients. Cravath is representing CymaBay in connection with the transaction.
Deals & Cases
February 12, 2024
On February 12, 2024, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that on February 11, 2024, it entered into a definitive agreement to acquire 20 active aggregates operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (“BWI Southeast”) for $2.05 billion in cash. Additionally, on February 9, 2024, Martin Marietta completed its previously announced divestiture of its South Texas cement and related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transactions.
Deals & Cases
January 31, 2024
On January 31, 2024, Health Care Service Corporation (“HCSC”), the country’s largest customer‑owned health insurer, announced that it has signed a definitive agreement with The Cigna Group (“Cigna”) to acquire its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies businesses for a purchase price of $3.3 billion. Cigna’s Medicare plans currently serve 3.6 million Medicare members. Cravath is representing HCSC in connection with the transaction.
Deals & Cases
January 25, 2024
On January 18, 2024, IBM announced it has signed a definitive agreement to acquire application modernization capabilities from Advanced, bringing a combination of talent, tools and knowledge to enhance IBM Consulting’s mainframe application and data modernization services. Cravath is representing IBM in connection with the transaction.
Deals & Cases
December 20, 2023
On December 20, 2023, Aon plc (“Aon”), a leading global professional services firm, announced the signing of a definitive agreement to acquire NFP, a leading middle‑market property and casualty broker, benefits consultant, wealth manager and retirement plan advisor, from funds affiliated with NFP’s main capital sponsor, Madison Dearborn Partners, and funds affiliated with HPS Investment Partners. Under the terms of the transaction, Aon will acquire NFP for a total consideration estimated to be $13.4 billion at the time of close, which will be funded by $7 billion of cash and $6.4 billion of Aon stock. Cravath is representing Aon in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.